Validation of performance of Spanish version of PURE-4 questionnaire for early identification of psoriatic arthritis after 1 year of follow-up in patients with psoriasis
The PURE-4 questionnaire offers good clinimetric capabilities for the early detection of PsA with a score ≥2. Of the total number of patients with PsA, one in four were detected one year after answering positively to the questionnaire, which would help to predict which patients are at high risk of developing PsA. The authors reinforce the recommendation to closely follow up with these patients.
Authors
- V. Rocamora-Duran
- A. López-Ferrer
- J. Santos-Juanes
- R. Queiro-Silva
- on behalf of Norwegian SARS-CoV-2 study group
- M. Ferran i Farrés
- R. Rivera-Díaz
- D. Vidal-Sarro
- I. Belinchón-Romero
- L. Rodríguez Fernández-Freire
- L. Gómez-Labrador
- P. de la Cueva-Dobao
Institutions
- Universitat de Miguel Hernández d'Elx (ES)
- Universidad Complutense de Madrid (ES)
- Hospital de Sant Pau (ES)
- Research Institute Hospital 12 de Octubre (ES)
- Fundación Hospital Manacor (ES)
- Hospital Del Mar (ES)
- Hospital de Sant Joan Despí Moisès Broggi (ES)
- Hospital Universitario Central de Asturias (ES)
- Hospital General Universitario de Alicante Doctor Balmis (ES)
- Novartis (Spain) (ES)
- Hospital Universitario Virgen del Rocío (ES)
- Hospital Universitario Infanta Leonor (ES)
Publication Details
- Journal
- PLoS ONE
- Published
- 2026-03-02
- DOI
- https://doi.org/10.1371/journal.pone.0342498
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00